Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Nasal Spray Influenza Vaccine Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, there has been a significant expansion in the market size of the nasal spray flu vaccine. Its growth is projected to escalate from a value of $1.31 billion in 2024, to about $1.48 billion in 2025. The compound annual growth rate (CAGR) during this time is estimated at 12.2%. The past growth in this sector is linked to factors such as better vaccine availability, heightened knowledge about the prevention of influenza, an increased emphasis on vaccinations for children, higher vaccination rates, and a growing popularity for vaccines that do not use needles.
In the upcoming years, significant expansion is anticipated in the market for nasal spray influenza vaccines, with projections estimating a value of$2.38 billion by 2029″ and a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this projected growth include an increase in the demand for easy-to-use immunization methods, a rising number of seasonal influenza cases, enhanced government endeavors and backing, anticipated rise in the elderly and high-risk demographics, and heightened implementation within healthcare environments. Key trends within the forecast period include advancements in vaccine dispensing systems, incorporation of mucosal immunity tactics, technological progress in viral vector platforms, developments in cold-chain technology, and the application of mRNA technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24326&type=smp
Which Primay Drivers Are Accelerating Growth in the Nasal Spray Influenza Vaccine Market?
The anticipated rise in the occurrence of influenza is projected to boost the nasal spray influenza vaccine market’s advancement. This highly contagious viral infection, which primarily impacts the respiratory system, causes symptoms like fever, cough, sore throat, body aches, and fatigue. The escalating prevalence of influenza chiefly occurs due to the influenza virus’s frequent genetic mutations, facilitating evasion from present immunity and quick spreading among populations. The nasal spray influenza vaccine works against influenza by introducing a weakened virus form directly into nasal passages, prompting an immune response at the typical virus entry point. As an illustration, the UK Health Security Agency, a government body in the UK, noted that between week 40 of 2022 and week 15 of 2023, 1,681 confirmed influenza-linked critical care admissions were reported by 108 NHS trusts in England. In contrast, the figures for the preceding season were significantly lower with only 182 admissions reported from 114 trusts, which increased to 316 admissions by week 39 of 2022. Thus, the escalating occurrence of influenza is contributing to the growth of the nasal spray influenza vaccine market.
Which Primary Segments of the Nasal Spray Influenza Vaccine Market Are Driving Growth and Industry Transformations?
The nasal spray influenza vaccinemarket covered in this report is segmented –
1) By Type: Live Attenuated Influenza Vaccine (LAIV); Inactivated Influenza Vaccine
2) By Administration Method: Single-Dose Administration; Multi-Dose Administration
3) By Age Group: Pediatric; Adult; Geriatric
4) By Distribution Channel: Hospitals; Clinics; Pharmacies; Online Stores; Other Distribution Channels
5) By End User: Healthcare Providers; Individuals; Government Health Departments; Pharmaceutical Companies
Subsegments:
1) By Live Attenuated Influenza Vaccine (LAIV): Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV); Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)
2) By Inactivated Influenza Vaccine: Whole Virus Inactivated Vaccine; Split Virus Inactivated Vaccine; Subunit Inactivated Vaccine; Adjuvanted Inactivated Vaccine; High-Dose Inactivated Vaccine
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24326&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Nasal Spray Influenza Vaccine Market?# Market?
North America was the largest region in the nasal spray influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal spray influenza vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Nasal Spray Influenza Vaccine Industry Dynamics?
Leading businesses in the nasal spray influenza vaccine market are striving to create innovative formulations like live attenuated influenza vaccine to boost the immune response and enhance patient adherence. The live attenuated influenza vaccine (LAIV) is a flu vaccine created from weak, live influenza viruses that stimulate the immune system to generate antibodies. This not only gives protection without causing the disease itself, but also offers a well-rounded immune response via both local and systemic immunity, improving the body’s defense against future influenza attacks. For example, in September 2024, the U.S. Food and Drug Administration (FDA) gave its approval to AstraZeneca Plc, a pharmaceutical company based in the UK, for FluMist (a live attenuated influenza vaccine (LAIV)). The vaccine is allowed to be self-administered by adults up to 49 years old or given by caregivers to children aged 2 to 17 years, marking it as the first and only influenza vaccine in the U.S. approved for either self- or caregiver-administration. This approval came after thorough usability studies showing that every participant was able to correctly administer the vaccine themselves, with all of them successfully delivering a full dose as directed.
View the full report here:
https://www.thebusinessresearchcompany.com/report/nasal-spray-influenza-vaccine-global-market-report
What Parameters Are Used to Define the Nasal Spray Influenza Vaccine Market?
Nasal spray influenza vaccine refers to a needle-free flu vaccine administered through the nose that uses live attenuated viruses to protect against seasonal influenza. Nasal spray influenza vaccine is utilized by spraying it into the nostrils, where it stimulates an immune response in the nasal passages to protect against seasonal flu.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24326
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model